Filing Details
- Accession Number:
- 0001140361-16-072623
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2016-07-15 18:17:28
- Reporting Period:
- 2016-07-13
- Filing Date:
- 2016-07-15
- Accepted Time:
- 2016-07-15 18:17:28
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1428336 | Healthequity Inc | HQY | Services-Business Services, Nec (7389) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1614866 | Ian Sacks | C/O Healthequity, Inc. 15 W. Scenic Pointe Dr., Ste. 100 Draper UT 84020 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2016-07-13 | 50,000 | $30.38 | 223,417 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2016-07-14 | 25,000 | $30.28 | 198,417 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2016-07-15 | 25,000 | $30.04 | 173,417 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Holdings
| Sec. Name | Sec. Type | Price | Date | Expiration Date | Amount | Remaning Holdings | Nature of Ownership |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (right to buy) | $21.27 | 2026-02-01 | 15,000 | 15,000 | Direct | |
| Common Stock | Restricted Stock Units | $0.00 | 1,342 | 1,342 | Direct | ||
| Common Stock | Stock Option (right to buy) | $14.00 | 2024-07-30 | 15,000 | 15,000 | Direct | |
| Common Stock | Stock Option (right to buy) | $25.39 | 2025-03-26 | 15,000 | 15,000 | Direct |
| Expiration Date | Amount | Remaning Holdings | Nature of Ownership |
|---|---|---|---|
| 2026-02-01 | 15,000 | 15,000 | Direct |
| 1,342 | 1,342 | Direct | |
| 2024-07-30 | 15,000 | 15,000 | Direct |
| 2025-03-26 | 15,000 | 15,000 | Direct |
Footnotes
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $30.07 to $31.03, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1), (2) and (3) to this Form 4.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $30.11 to $30.50, inclusive.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $29.95 to $30.24, inclusive.
- The option became exercisable as to 7,500 shares upon the reporting person's reelection to the issuer's board of directors at the issuer's 2016 Annual Meeting of Stockholders held on June 23, 2016. The remaining 7,500 shares will become exercisable on January 31, 2017; provided, that the reporting person continues to serve as a director of the issuer through such date.
- Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock.
- The restricted stock units vested as to 447 shares on May 1, 2016. The remaining restricted stock units vest as to 447 shares on August 1, 2016 and as to 448 shares on November 1, 2016. Vested shares will be delivered to the reporting person on January 1, 2018.
- These options are immediately exercisable.
Billionaire Hedge Funds
